(Q41680549)

English

High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply

scientific article published on 2 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 October 2017

High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply (English)

1 reference

Europe PubMed Central

7 October 2017

author name string

Xin Zheng

1

1 reference

Europe PubMed Central

7 October 2017

Xianlin Ye

2

1 reference

Europe PubMed Central

7 October 2017

Peng Du

3

1 reference

Europe PubMed Central

7 October 2017

Jinfeng Zeng

4

1 reference

Europe PubMed Central

7 October 2017

Weigang Zhu

5

1 reference

Europe PubMed Central

7 October 2017

Baocheng Yang

6

1 reference

Europe PubMed Central

7 October 2017

Chengyao Li

7

1 reference

Europe PubMed Central

7 October 2017

Jean-Pierre Allain

8

1 reference

Europe PubMed Central

7 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 November 2014

1 reference

Europe PubMed Central

7 October 2017

1 reference

Europe PubMed Central

7 October 2017

55

1 reference

Europe PubMed Central

7 October 2017

4

1 reference

Europe PubMed Central

7 October 2017

890-897

1 reference

Europe PubMed Central

7 October 2017

Challenges in hepatitis B detection among blood donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Nucleic acid testing to detect HBV infection in blood donors.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Characterization of occult hepatitis B virus infection from blood donors in China

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Molecular characterization of occult hepatitis B virus in genotype E-infected subjects

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Determination of immune memory to hepatitis B vaccination through early booster response in college students.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Two cases of asymptomatic HBV "vaccine breakthrough" infection detected in blood donors screened for HBV DNA.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Infectivity of blood products from donors with occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12902

21 January 2018

Identifiers

10.1111/TRF.12902

1 reference

Europe PubMed Central

7 October 2017

1 reference

Europe PubMed Central

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41680549&oldid=1925875001"